PI3K/Akt pathway inhibitor

Related by string. * PI3K/AKT : PI3K/Akt . PI3K/Akt pathway / PATHWAY . PATHWAYS . Pathways . PathWays . pathways : +#.# % =mitochondrial pathway . Notch signaling pathway . Notch pathway . neural pathways . signaling pathway / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI . ACE inhibitors * *

Related by context. Frequent words. (Click for all words.) 77 Panzem R 74 liposomal formulation 74 R sorafenib tablets 73 refractory chronic lymphocytic 73 proteasome inhibitor 71 Phase Ib II 71 Tesetaxel 70 Initiates Phase II 70 anticancer compound 70 Thiarabine 70 Gemzar ® 70 humanized anti 70 MEK inhibitor 70 forodesine 70 deforolimus 70 Nexavar ® 69 multi kinase inhibitor 69 Nanobody 69 HCV protease inhibitor 69 PEG SN# 69 ThermoDox R 69 Epratuzumab 69 JAK inhibitor 69 Azedra 69 pertuzumab 69 sodium Injection 68 enzastaurin 68 Genasense R oblimersen 68 ATL# [001] 68 Cloretazine R VNP#M 68 relapsed refractory multiple myeloma 68 preclinical efficacy 68 IMC #B 68 acute promyelocytic leukemia APL 68 INCB# [001] 68 Factor VIIa 68 HGS ETR2 68 Voreloxin 68 Pivotal Phase III 68 RGB # 68 ganetespib 68 ixabepilone 68 Daclizumab 67 ongoing Phase 1b 67 L Annamycin 67 investigational compounds 67 Proxinium TM 67 Pralatrexate 67 Diamyd R 67 elotuzumab 67 HER2 positive metastatic breast 67 Aurora kinase 67 anti fibrotic 67 multiple myeloma MM 67 vascular disrupting agent 67 CCX# 67 JAK1 67 humanized monoclonal antibody 67 targeting CD# 67 PXD# 67 orally bioavailable 67 phase IIa clinical 67 KRN# 67 phase IIb clinical 67 Initiate Phase 67 Dapagliflozin 66 Acute Myeloid Leukemia AML 66 GRNVAC1 66 tanespimycin 66 Amrubicin 66 PLK1 SNALP 66 BAY #-# 66 Genasense ® 66 MKC# 66 RH1 66 Receives Orphan Drug Designation 66 TLR9 agonists 66 epothilone 66 novel orally administered 66 CYC# 66 theranostic 66 Trofex 66 metastatic castrate resistant 66 Traficet EN 66 sunitinib malate 66 Ixempra 66 PSN# [002] 66 Commences Phase 66 castrate resistant prostate cancer 66 TELINTRA 66 talactoferrin 66 nitric oxide donating 66 mTOR inhibitor 66 Cetrorelix 66 Mipomersen 66 AEG# 66 BN# [002] 66 Eculizumab 66 ANYARA 66 renin inhibitors 65 romidepsin

Back to home page